Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Influenza Clinical Trials

101 recruiting trials for Influenza. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
101
Total Trials
101
Recruiting Now
16
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06848309

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

The purpose of this study is to evaluate the virus-specific immune response in people who are symptomatic with confirmed influenza or COVID-19. We will study the immune response...

Sponsor: Washington University School of MedicineEnrolling: 3001 location
RECRUITINGNCT06640387

CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools

Viral respiratory tract infections are very common in children. They contribute to missed time in school, work disruption for caregivers and can also cause severe illness...

Sponsor: The Hospital for Sick ChildrenEnrolling: 5001 location
RECRUITINGPhase 4NCT05045612

Antibiotic Therapy in Viral Airway Infections

Antimicrobial resistance is one of the most urgent health threats of our time, and Norwegian hospitals were required to reduce the use of broad-spectrum antibiotics with 30% by...

Sponsor: University Hospital, AkershusEnrolling: 38012 locations
RECRUITINGNCT06160128

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

The purpose of this study is to comprehensively describe the temporal and geographic utilization of COVID-19 therapies used for mild to moderate disease during different periods...

Sponsor: VA Office of Research and DevelopmentEnrolling: 4000001 location
RECRUITINGNCT07030075

SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE...

Background and rationale:The World Health Organisation (WHO), estimates influenza global deaths at 290,000 to 650,000 annually. Although influenza is mostly associated with upper...

Sponsor: Centre for Infectious Disease Research in ZambiaEnrolling: 5942 locations
RECRUITINGNCT06155188

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

To determine if the novel regimen of PT/FLU+CY promotes cord blood engraftment in children's leukemia HSCT cohort

Sponsor: Nanfang Hospital, Southern Medical UniversityEnrolling: 601 location
RECRUITINGPhase 2NCT05215327

High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Lung allograft recipients have a higher burden of influenza disease and greater associated morbidity and mortality compared with healthy controls. Induction and early maintenance...

Sponsor: Vanderbilt University Medical CenterEnrolling: 2701 location
RECRUITINGPhase 1 / Phase 2NCT06824519

Clinical Trials of Quadrivalent Influenza Vaccine

This clinical trial adopts a seamless design of phase I/II, conducted in two stages: phase I and phase II. Phase I is the age/dose ramp up stage, and phase II is the dose...

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Enrolling: 6201 location
RECRUITINGNCT07358910

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure...

Sponsor: Institut Pasteur du CambodgeEnrolling: 100001 location
RECRUITINGNCT04772170

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Background: Respiratory viruses circulate throughout the year and around the globe. Wearable and sensor devices, like smartwatches, may be able to help monitor infectious...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 10001 location
RECRUITINGPhase 1NCT06753474

A/Texas Flu Challenge

This study is designed to help us better understand how the immune system responds to the flu and how flu is transmitted in the environment. The ultimate goal is to develop better...

Sponsor: Emory UniversityEnrolling: 502 locations
RECRUITINGPhase 1NCT07044544

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

The purpose of this study is to determine the safety of adding Decitabine and Venetoclax to patients undergoing reduced intensity allogenic transplantation for treatment of...

Sponsor: University of Alabama at BirminghamEnrolling: 201 location
RECRUITINGPhase 3NCT07240558

Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)

Influenza is an important pathogen in transplant recipients. The current widespread outbreak of highly pathogenic H5N1 avian influenza (HPAI) in livestock, and the occurrence of...

Sponsor: University Health Network, TorontoEnrolling: 1201 location
RECRUITINGPhase 1NCT07110532

pH1N1 Blinded Challenge Study

This protocol describes a clinical trial to develop and validate a Controlled Human Infection Model (CHIM) for influenza A/Arkansas/08/2020 (pH1N1). The study is designed to...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 1802 locations
RECRUITINGNCT06620185

GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

This experimental medicine study aims to compare immune responses in healthy adult volunteers aged 18-40 years against influenza vaccination and infection in the upper and lower...

Sponsor: Imperial College LondonEnrolling: 361 location
RECRUITINGPhase 1NCT06859333

Study of the Safety, Tolerability, and Pharmacokinetic Profile of Ascending Doses of Ingavirin Forte, Capsules,...

This is a Single Center, First-in-human Study of Safety, Tolerability, and Pharmacokinetic Profile of Ascending Single and Multiple Doses of Ingavirin Forte, Capsules in Healthy...

Sponsor: Valenta Pharm JSCEnrolling: 361 location
RECRUITINGPhase 2NCT05275686

Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)

Intranasal nasal steroid sprays are the mainstay of treatment for chronic Eustachian tube dysfunction despite having little supportive evidence in the literature. A novel,...

Sponsor: Cedars-Sinai Medical CenterEnrolling: 804 locations
RECRUITINGNCT06446232

Influenza Vaccine Effectiveness in Among Young Children in Taiwan

This project uses questionnaires to statistically analyze whether influenza vaccination is protective for young children.

Sponsor: National Taiwan University HospitalEnrolling: 11 location
RECRUITINGPhase 1 / Phase 2NCT06684379

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of...

The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B) of Standardized Conditioned Medium Obtained by Coculture...

Sponsor: PEACHES BIOTECHEnrolling: 501 location
RECRUITINGNCT06784739

COMMUNITY - the COVID-19 Immunity Study

The principal aim of the COMMUNITY study is to investigate immune responses following SARS-CoV-2 infection and/or vaccination in healthcare workers and hospitalized COVID-19...

Sponsor: Danderyd HospitalEnrolling: 55002 locations
RECRUITINGNCT06998251

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With...

The NoseSpn-Elderly study aims at characterizing the immune response in the upper respiratory tract in adults aged 60 and over diagnosed with a pneumonia due to a Streptococcus...

Sponsor: University Hospital, GenevaEnrolling: 2801 location
RECRUITINGPhase 4NCT05585983

INfluenza VaccInation To Mitigate typE 1 Diabetes

In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.

Sponsor: Aarhus University HospitalEnrolling: 10010 locations
RECRUITINGNCT04367883

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

Some authors have proposed the use of the flu vaccine to reduce the severity of COVID-19 cases, while some have proposed the use of ACE Inhibitors (ACEI) or Angiotensin Receptor...

Sponsor: Consorci Sanitari de TerrassaEnrolling: 30001 location
RECRUITINGNCT06676644

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to...

To compare the immunogenicity, cellular immune response, and safety between adjuvanted (aIIV4) and non-adjuvanted (IIV4) seasonal influenza vaccines in the Taiwanese elderly...

Sponsor: National Taiwan University HospitalEnrolling: 2001 location
RECRUITINGPhase 2NCT05291676

Systems Investigation of Vaccine Responses in Aging and Frailty

This study will compare the immune response signatures (including immunologic, transcriptomic and metabolomic) of the two influenza vaccines approved for use in adults age 65 and...

Sponsor: Yale UniversityEnrolling: 961 location
RECRUITINGNCT06156254

Community Care Intervention to Decrease COVID-19 Vaccination Inequities

The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults...

Sponsor: RANDEnrolling: 8004 locations
RECRUITINGNCT07278700

The Fever Clinic Acute Respiratory Cohort

This prospective cohort study aims to characterize the natural progression and outcomes of acute respiratory infections among patients presenting to fever clinics. At enrollment,...

Sponsor: Fudan UniversityEnrolling: 10001 location
RECRUITINGNCT06998264

In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children

The NoseFlu-Kids project aims at characterizing the immune response in the upper respiratory tract in children aged 2 to 5 with a laboratory-confirmed influenza infection. The...

Sponsor: University Hospital, GenevaEnrolling: 401 location
RECRUITINGPhase 3NCT04381936

Randomised Evaluation of COVID-19 Therapy

RECOVERY is a randomised trial of treatments to prevent death in patients hospitalised with pneumonia. The treatments being investigated are: COVID-19: Lopinavir-Ritonavir,...

Sponsor: University of OxfordEnrolling: 700007 locations
RECRUITINGPhase 3NCT07095257

Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years...

The goal of this phase III study is to learn if ZX-7101A for oral suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years. The main...

Sponsor: Nanjing Zenshine PharmaceuticalsEnrolling: 1682 locations
RECRUITINGNCT07007377

Can the Ergometric Test in Flu-like Syndrome Help in the Outcome Analysis of Unvaccinated Patients

During the flu-like syndrome, the cardiovascular risk is increased, especially in the elderly. Understanding whether blood pressure assessment during an exercise test can aid in...

Sponsor: University of Sao PauloEnrolling: 1501 location
RECRUITINGPhase 4NCT05108818

Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific...

Sponsor: University of PennsylvaniaEnrolling: 7001 location
RECRUITINGPhase 3NCT07357051

Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric...

The goal of this phase III study is to learn if JKN2301 Dry Suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years.

Sponsor: Joincare Pharmaceutical Group Industry Co., LtdEnrolling: 1771 location
RECRUITINGNCT03748069

Influenza Associated Aspergillosis In-depth Investigation

This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.

Sponsor: Universitaire Ziekenhuizen KU LeuvenEnrolling: 451 location
RECRUITINGPhase 4NCT05518500

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults

This is a prospective, single-arm study designed to understand the mechanisms that lead to a loss of response to influenza vaccine in older adults. The investigators will recruit...

Sponsor: The Jackson LaboratoryEnrolling: 751 location
RECRUITINGNCT06692400

The Effects of Endotracheal Suctioning on Pain and Serum Markers

The goal of this experimental study is to understand if endotracheal tube (ETT) suctioning increases pain and causes stress on the body in intubated adult ICU patients. These...

Sponsor: Loma Linda UniversityEnrolling: 1101 location
RECRUITINGPhase 3NCT06573008

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

This study will evaluate the efficacy, safety, and population pharmacokinetics of a single, oral dose of GP681 compared with placebo in patients aged 12 and older With Influenza...

Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.Enrolling: 3281 location
RECRUITINGNCT07259252

Influenza Vaccination After Acute Coronary Syndrome

The goal of this clinical trial is to learn if influenza vaccination can prevent adverse cardiac events in Chinese acute coronary syndrome patients. The main questions it aims to...

Sponsor: Tongji HospitalEnrolling: 66201 location
RECRUITINGNCT06029933

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

This study will evaluate the relative vaccine effectiveness of quadrivalent adjuvanted inactivated influenza vaccine (aIIV4) versus quadrivalent high-dose inactivated influenza...

Sponsor: Kaiser PermanenteEnrolling: 9600001 location
RECRUITINGPhase 4NCT05616546

Bone Marrow and Peripheral Blood Immune Responses Study

The purpose of this study is to evaluate the immune response of the killed flu vaccine in healthy subjects. Participants in this study are considered to be healthy volunteers....

Sponsor: Emory UniversityEnrolling: 901 location
RECRUITINGPhase 3NCT06574503

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

Index patients who are infected with influenza virus (Q-PCR positive) can be treated with anti-influenza drugs if their influenza symptoms onset was within 48 hours of screening....

Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.Enrolling: 7481 location
RECRUITINGPhase 1NCT05332899

Influenza Human Challenge Model

This study examines how the immune system responds to the flu virus (H3N2) during and after infection and how the flu virus is transmitted in the environment. The study will used...

Sponsor: Emory UniversityEnrolling: 802 locations
RECRUITINGNCT07359287

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

Antimicrobial resistance (AMR), considered one of the greatest global threats by the WHO, justifies the development of initiatives to promote appropriate antibiotic use-especially...

Sponsor: University Hospital, CaenEnrolling: 45001 location
RECRUITINGPhase 1NCT07464314

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of its safety and how it builds protection. Healthy...

Sponsor: GlaxoSmithKlineEnrolling: 2252 locations
RECRUITINGPhase 2NCT07420985

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at...

The objective of this study is to investigate the efficacy, safety, and tolerability of investigational product Ingavirin forte capsules (Valenta Pharm JSC) administered at...

Sponsor: Valenta Pharm JSCEnrolling: 30011 locations
RECRUITINGNCT01386424

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

Background: * The Laboratory of Infectious Diseases (LID) Clinical Studies Unit (CSU) enrolls healthy volunteers into clinical studies to study infectious diseases. * Viruses can...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 50001 location
RECRUITINGPhase 4NCT07177417

Characterizing the Human Airway Immune Response to FluMist Vaccination

The goal of this clinical trial is to measure the immune response in the blood, nose, and lungs after participants receive either the FDA-approved inactivated influenza vaccine or...

Sponsor: Washington University School of MedicineEnrolling: 301 location
RECRUITINGPhase 3NCT07496450

A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of...

Sponsor: ModernaTX, Inc.Enrolling: 400020 locations
RECRUITINGPhase 2NCT04712539

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

This phase II trial studies the effect of baloxavir in combination with oseltamivir in treating severe influenza infection in patients who have previously received a hematopoietic...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 601 location
RECRUITINGNCT07431840

Immune Defense Protein Impact On Respiratory Immune Outcomes

The primary goal of this study is to observe the impact of the IDP® Supplement on the duration and severity of upper respiratory symptoms in older individuals during the cold and...

Sponsor: Quantec LtdEnrolling: 3001 location

Showing 50 of 101 trials.Search all Influenza trials